Prosetta in-licenses IP from Chiron for Hepatitis C research
06.22.04 - Chiron Corporation announces non-exclusive license to Prosetta Corporation for IP related to Hepatitis C research. Under the terms of the agreement Prosetta is not required to make upfront payment of licensing fees.
